NASDAQ:NKGNW

NKGen Biotech (NKGNW) Stock Price, News & Analysis

$0.11
-0.03 (-23.40%)
(As of 01:52 PM ET)
Today's Range
$0.11
$0.12
50-Day Range
$0.07
$0.20
52-Week Range
$0.03
$0.73
Volume
1,004 shs
Average Volume
25,359 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About NKGen Biotech

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials. The company was founded in 2017 and is based in Santa Ana, California.

NKGNW Stock Price History

NKGNW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive NKGNW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:NKGNW
Fax
N/A
Employees
63
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$77,000.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Paul Y. Song M.D. (Age 58)
    CEO & Chairman
    Comp: $36.58M
  • Mr. Sangwoo Park (Age 54)
    Executive Director
    Comp: $576k
  • Mr. James A. Graf (Age 59)
    Interim CFO
  • Mr. Pierre Gagnon (Age 52)
    Chief Operating Officer
  • Ms. Yoonmi Kang
    Vice President of Technical Operations
  • Dr. Yong Man Kim Ph.D. (Age 59)
    Chief Scientific Officer
  • Ms. Denise A. Chua CLS
    MBA, MT (ASCP), Vice President of Investor Relations & Corporate Communications
  • Ms. Irene Chang
    Vice President of Human Resources
  • Mr. Ryan Park C.F.A.
    SVP of Financial Planning & Analysis and Corporate Strategy

NKGNW Stock Analysis - Frequently Asked Questions

How have NKGNW shares performed in 2024?

NKGen Biotech's stock was trading at $0.0808 at the beginning of 2024. Since then, NKGNW stock has increased by 39.4% and is now trading at $0.1126.
View the best growth stocks for 2024 here
.

How do I buy shares of NKGen Biotech?

Shares of NKGNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NKGNW) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners